Company page
Genome & Co.
Genome & Co. is a public company listed under the ticker 314130 on the Korean market. The company has a market capitalization of approximately 153.56 million USD. Genome & Co. focuses on advancements in genomic research and technology.
- Ticker
- 314130:KRX
- Asset type
- Stock
- Market cap
- $153.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW